Trimetazidine reduces endogenous free fatty acid oxidation and improves myocardial efficiency in obese humans

Cardiovascular Therapeutics, 04/30/2012

In obese subjects, authors demonstrate that myocardial intracellular triglyceride oxidation significantly provides FA–derived energy for mechanical work. Trimetazidine (TMZ) reduced the oxidation of triglyceride–derived myocardial FAs improving myocardial efficiency.

Print Article Summary Cat 2 CME Report